Viking Therapeutics, Inc. (VKTX)
30.27
-1.44
(-4.54%)
USD |
NASDAQ |
May 15, 16:00
30.45
+0.18
(+0.59%)
After-Hours: 20:00
Viking Therapeutics Market Cap : 3.515B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 896.13B |
| Amgen, Inc. | 176.21B |
| Catalyst Pharmaceuticals, Inc. | 3.816B |
| Altimmune, Inc. | 555.22M |
| TG Therapeutics, Inc. | 6.050B |
Market Cap Related Metrics
| PEG Ratio | -0.0281 |
| Price to Book Value | 7.002 |
| Price | 30.27 |
| Earnings Yield | -13.70% |
| PEGY Ratio | -0.0281 |